MAR 15, 2016 12:05 PM PDT

Protecting Babies From Serious Lung Infections

WRITTEN BY: Kara Marker
For healthy adults and older children, respiratory syncytial virus (RSV) is not a serious issue, but the infection can be life-threatening for infants and young children. New human and mouse studies have identified a naturally-produced compound that fights RSV, and now scientists are looking for ways to naturally boost its production.
                        
RSV is common and usually just produces cold-like symptoms. However for infants and young children at a heightened risk for RSV, those regularly attending daycare, experiencing second-hand smoke, have school-aged siblings, or endure crowded living situations, RSV infection can become quite severe (Medline Plus). There are several symptoms that accompany a serious RSV infection:
  • Cyanosis
  • Difficulty breathing
  • Nasal flaring
  • Wheezing
When severe RSV infections cause hospital visits, treatment can consist of oxygen, humidified air, IV fluids, and ventilation.
 
RSV Structure

 
In their study of mice and healthy adults published in the Journal of Immunology, University of Edinburgh scientists at the MRC Centre for Inflammation Research pinpointed a naturally-produced compound called cathelicidin as having a large role in the immune attack against RSV. During their study, mice unable to produce cathelicidin like normal were more susceptible to RSV infection. However, when simultaneously treated with cathelicidin during their RSV infection, their bodies were able to fight off the infection like normal mice.
 
Humans, too, had a clear connection to cathelicidin. Healthy adults who produced lower levels of cathelicidin, for unknown reasons so far, were more susceptible to RSV, like the mice who could not produce the compound at all. Based on these findings, scientists are hoping to find ways to “encourage” the immune system to produce more cathelicidin, especially for high-risk groups of infants and young children.
 
Cathelicidin works by directly attacking RSV particles, preventing them from attaching to and penetrating host cells. Cathelicidin could also be a new therapy for RSV, and scientists are especially looking for natural ways to boost compound production.
 
Enhancing the treatment arsenal for RSV is certainly beneficial for infants and young children, but it is also valuable for elderly people who, like infants, constitute a population especially vulnerable to life-threatening versions of the disease.
 
“Boosting the body's natural defenses could be a useful therapeutic approach to stop RSV infection from turning into a life-threatening infection in babies and vulnerable adults,” said Dr. Donald Davidson.
 
Davidson and other Edinburgh scientists are asking this question next: why do people differ in the amount of cathelicidin they produce?
 
 
Source: University of Edinburgh
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 30, 2021
Drug Discovery & Development
Exosome delivery of an anti-HIV drug to the brain
SEP 30, 2021
Exosome delivery of an anti-HIV drug to the brain
The body has a remarkable ability to prevent foreign objects, such as toxins or other pathogens, from entering the brain ...
OCT 01, 2021
Microbiology
Understanding How the Gut Microbiome is Affected by Temperature
OCT 01, 2021
Understanding How the Gut Microbiome is Affected by Temperature
The gut microbiome has become an area of intense research focus in recent years. Genomic tools have enabled scientists t ...
SEP 30, 2021
Cannabis Sciences
Concerning New Evidence Regarding Cannabis Use During Pregnancy
SEP 30, 2021
Concerning New Evidence Regarding Cannabis Use During Pregnancy
According to data from a National Vital Statistics Report published in March 2021, the percentage of infants born with a ...
OCT 03, 2021
Coronavirus
Merck's COVID-19 Drug Halves Risk of Death in Mild & Moderate Cases
OCT 03, 2021
Merck's COVID-19 Drug Halves Risk of Death in Mild & Moderate Cases
While Dr. Anthony Fauci of NIAID is already stressing that people should still get vaccinated to help reduce COVID-19 in ...
OCT 19, 2021
Cell & Molecular Biology
Mouse Fathers Passed Immunity Onto Offpsring After Infection
OCT 19, 2021
Mouse Fathers Passed Immunity Onto Offpsring After Infection
Parents pass their genes on to their children. But they can pass down other things too with epigenetic marks, chemical t ...
OCT 22, 2021
Health & Medicine
Galactic Cosmic Radiation Could Have Different Effects on Males and Females
OCT 22, 2021
Galactic Cosmic Radiation Could Have Different Effects on Males and Females
As commercial spaceflight becomes readily available, more and more people will have access to space. In decades past, on ...
Loading Comments...